Epivir (3TC, Lamivudine)

The Latest

Dovato Is a Newly Approved Two-Drug HIV Regimen. Do Fewer Drugs Mean a Lower-Cost HIV Treatment?

Advocates say the price is a step in the right direction. But does it go far enough?

By Tim Murphy

An Overview of Epivir (3TC, Lamivudine)

Brand Name: Epivir Other Name(s): 3TC Drug Class: Nucleoside reverse transcriptase inhibitors

By AIDSinfo

Lamivudine (Epivir)

What Is Lamivudine? Who Should Take Lamivudine? What About Drug Resistance? How Is Lamivudine Taken? What Are the Side Effects? How Does Lamivudine React With Other Drugs?

What Is Lamivudine?

Lamivudine (Epivir) is a drug used as part o...

By AIDS InfoNet


Brand name: Epivir

Generic name: lamivudine, or 3TC

Class: Nucleoside reverse transcriptase inhibitor (nucleoside, NRTI, or nuke)

Manufacturer: ViiV Healthcare, www.viivhealthcare.com, (877) 844-8872

AWP: $498.90/month for 300 mg tablets; $429.66...

By Positively Aware

Epivir (Lamivudine)

Epivir tablets are film-coated, white, and diamond-shaped with the dosage "150" imprinted on one side and "GX CJ7" on the other side. This drug is also available in a flavored solution.

Background and Description Coformulations Dose Food Restr...

By The Center for AIDS Information & Advocacy

Evaluation of Novel Combination of Abacavir, Lamivudine and Efavirenz

Use of efavirenz in a low-income population (Poster, WePeB4138) Authored by D. Parrish, J. Godbey Evaluation of novel combination of abacavir (ABC), lamivudine (3TC) and efavirenz (EFV) (Poster, WePeB4139) Authored by J. Godbey, D. Parris...

By Calvin Cohen, M.D., M.S.

Efavirenz + Zidovudine + Lamivudine Provides Superior Long-Term HIV-RNA Suppression, Antiretroviral Activity and Tolerability Versus Indinavir + ZDV + 3TC: Results of Study 006 at 72 Weeks (Initial Cohort)

Abstracts 14, 314 and 366

Abstract 14: A Comparison of d4T, ddI, and indinavir (IDV) with ZDV, 3TC, and IDV as the Initial Treatment of HIV-1: Selection of Thymidine Analog Regimen Therapy (Start II) Authored by Joseph J. Eron, Robert L. Murphy,...

By Ian Frank, M.D.

Characterization of Lamivudine Pharmacokinetics in Cerebrospinal Fluid and Plasma by Ultra-Intensive Sampling

Abstracts 330, 338, 339, and 340

Abstract 330: Characterization of Lamivudine (3TC, Epivir) Pharmacokinetics in Cerebrospinal Fluid (CSF) and Plasma by Ultra-Intensive Sampling Authored by L.A. Clough, C.V. Fletcher, D. Weller, B. Johnson, P. Sp...

By Daniel Kuritzkes, M.D.

Antiviral Activity and Acceptance of Two Different Triple Combinations

d4T + Indinavir + 3TC Vs d4T + Indinavir + ddI

In this study by a Spanish research group led by N. Villalba, 96 AZT-experienced patients with fewer than 350 CD4 cells/mm3 received standard doses of the nucleoside analog d4T in combination with the p...

By Kent Sepkowitz, M.D.

Session 50, Abstract 379: Combination Therapy with AZT + 3TC + Indinavir vs. d4T + 3TC + Indinavir in Pretreated Patients with Less than 200 CD4/mm3

In this non-randomized study, Dr. Rubio and colleagues looked at the efficacy and tolerance of combination therapy with AZT + 3TC + indinavir as compared to d4T + 3TC + indinavir. They enrolled forty-four pre-treated patients (either AZT and/or ddI a...

By Kent Sepkowitz, M.D.